Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetesYuan Zou, Cong-Yi Wang|Molecular Medicine|2024Cited by 7
Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetesYuan Zou, Cong-Yi Wang|Research Square|2023Cited by 0